MIND Foundation

22/12/2025

22/12/2025

06/12/2025

Most people who could benefit from psilocybin therapy are never allowed into clinical trials!

Their symptoms are too severe and the rules too strict.

Germany’s new Compassionate Use program changes that.
For the first time in the EU, patients with treatment-resistant depression can legally receive psilocybin therapy outside of clinical trials — safely, ethically, and with fewer exclusion barriers.

For many, this is the only remaining path to relief.
But access is still limited. The treatment is not covered by public health insurance.

Your contribution helps make psilocybin therapy available to those who have run out of options.
You can fund treatment directly for a patient — or help us expand access to this breakthrough therapy.

Help bring psilocybin therapy to those who need it most.
[ Donation link: in the comments and it will be added in bio on Monday :)) ]

If you want to know more about the Compassionate Use program or for patient inquiries, find the link in bio.

06/12/2025

Most people who could benefit from psilocybin therapy are never allowed into clinical trials.
Their symptoms are too severe and the rules too strict.

Germany’s new Compassionate Use program changes that.
For the first time in the EU, patients with treatment-resistant depression can legally receive psilocybin therapy outside of clinical trials — safely, ethically, and with fewer exclusion barriers.

For many, this is the only remaining path to relief.
But access is still limited. The treatment is not covered by public health insurance.

Your contribution helps make psilocybin therapy available to those who have run out of options.
You can fund treatment directly for a patient — or help us expand access to this breakthrough therapy.

Help bring psilocybin therapy to those who need it most.
[Donation link in bio ]

If you want to know more about the Compassionate Use program or for patient inquiries, find the link in bio.

13/11/2025

Last Friday, more than 100 guests joined our MIND Foundation × OVID Clinic symposium at Berlin Science Week to discuss a milestone for psychedelic therapy: Germany’s first Compassionate Use program for psilocybin.

🎙️ Andrea Jungaberle opened the event with a clear statement:

“What we have here in Germany is the first true Compassionate Use program in the European Union.”

It is a regulatory breakthrough—and a major responsibility.
Many patients with long treatment histories now have reason to hope.
Yet compassionate use is not broad access, and even when treatment becomes available, success is not guaranteed.
As psilocybin-assisted psychotherapy providers, we carry full responsibility, including managing patients’ expectations.

Marvin Däumichen and Inna Krylovetska continued by exploring the cognitive, philosophical, and social dimensions of psychedelic experience.
They emphasized that psychedelics can increase both the frequency and the felt truth of insights—including false ones, which may lead to false beliefs—and why community and integration are essential:

“Hearing in an integration circle that someone else has gone through a similar experience can offer incredible support.”

📊 Christopher Schmidt presented new qualitative data from his PhD research and the EPIsoDE Study,
and Dr. Henrik Jungaberle outlined the next major step:
The DiMension Trial, a Phase III HTA study comparing psilocybin-assisted psychotherapy with antidepressant-based treatment.
This evidence will be key to integrating psychedelic therapy into public health care.

💡 As a non-profit organization preparing such a large study, we are still looking for additional philanthropic funders that want to support a breakthrough innovation in mental health.

The session concluded with a lively panel discussion on clinicians’ experiences with psychedelic therapy.
Later, MIND Members gathered for dinner, closing an intense and inspiring day with social connection :)

15/10/2025

Join us at the fifth edition of the ALPS Awareness Lectures on Psychedelic Science! 🧠
foundation invites you to Campus Biotech in Geneva, October 24–25 for two days of psychedelic science, connection, and insights.

The conference features 16 speakers, panel discussions, poster presentations, a networking apéro, and an afterparty. Participants can earn up to 14 continuing education credits. Meet with researchers, clinicians, students, and curious minds from around the world to explore the latest psychedelic research.

Pass by our booth and say hello - see you there!

Friday and Saturday October 24 and 25, 2025
Campus Biotech in Geneva, Switzerland

Tickets in bio!

14/10/2025

We’re exctied to be in Munich next week for a German-language event!

Wie klingen die Echos unserer inneren Welten?

Die Neuroscience & Psychology Section veranstaltet unter der Leitung von Stela Malvasija ein Event in München und lädt alle dazu ein!

Am 23.10.2025 verwandelt sich das Bahnwärter Thiel in einen Resonanzraum für Bewusstsein, Wissenschaft und Kunst.

Wir beginnen mit einer Einführung in die Arbeit der MIND Foundation, gefolgt von einem Impuls zu „Altered States of Consciousness“ – wie veränderte Bewusstseinszustände unser Verständnis von Psyche, Transformation und Kollektiv erweitern können.
Danach öffnen wir den Raum für das, was bleibt, wenn die Erfahrung nachklingt: Integration. An diesem Tag vorgestellt durch verschiedene künstlerische Kanäle: Musikerinnen, Poetinnen, Comedians, Künstlerinnen und Magier lassen uns spüren, wie sich Wahrnehmungszustände in kreativen Ausdruck verwandeln.

INNER ECHOES lädt euch ein, zu lauschen, zu fühlen und Teil eines kollektiven Echoes zu werden.

📅 Donnerstag, 23 Oktober
⏱️ 18:00/19:00 - 21:45
📍 Bahnwärter Thiel, München

Tickets in Bio!

23/09/2025

🎥 uniMIND Symposium Prague Replay

“Ontological Shock & Psychedelic Transformation”

In this talk, Eirini Argyri, PhD candidate at the University of Exeter and researcher with the Challenging Psychedelic Experiences Project, explores how psychedelics disrupt our basic assumptions about self, reality, and existence.

Drawing on interviews and surveys, Argyri introduces the concept of ontological shock: a deep existential rupture that can spark profound transformation. She explores the emotional and cognitive challenges of integration: confusion, disorientation, existential distress - and how people rebuild meaning after these shifts.

Watch the full talk — link in bio!

22/09/2025

📚✨ Journal Club Invitation ✨📚
Join us for an academic journal club with Dr. Christian Greer on his article “Historians on Drugs: Toward an Empirical Historiography of Global Psychedelic Cultures.” 🌍

🗓 Tuesday, Sept 23
⏰ 7:00–8:00 pm CEST
📍 Zoom (link in bio)

Open to members & non-members alike! Come ready to share your thoughts and questions. If you can, read the article in advance — every participant helps shape the conversation.
Find the article on read.dukeupress.edu
Let’s rethink the history of psychedelics together — beyond clichés of “renaissance” or “dark ages” — and explore how culture, religion, and science weave into the story of human consciousness.

21/08/2025

🎥 uniMIND Symposium Prague Replay

“Insights from Neuroimaging Field Studies: DMT & 5-MeO-DMT”

In this talk, Marek Nikolíč, doctoral researcher at the National Institute of Mental Health under Dr. Tomáš Palenicek, dives into the neural signatures of two fast-acting psychedelics: DMT and 5-MeO-DMT.

🧠 Drawing on EEG data from three real-world contexts - a festival, underground therapy, and guided facilitation - Marek explores how these substances shape consciousness through changes in spectral dynamics, signal complexity, and neural timescales.

Watch the full video through the link in bio!

 

20/08/2025

“It gave me as a psychiatrist a bigger knowledge on consciousness and on psychological functioning in a broader perspective.”

APT teaches how to apply practical guidelines in psychedelic therapy – derived from the experience in psychedelic studies and thousands of sessions in clinical work – in your day-to-day work in a clinic. Psychedelic therapy is psychotherapy. Participants learn how to apply “disruptive” pharmacological and non-pharmacological tools to induce altered states of consciousness based on a legal, safe, evidence-based and accessible framework.

Interested in becoming a psychedelic therapist? Apply using the links in our bio!